Table 1.
Case | Age | Sex | Stage | Growth Pattern | Tumor Grade | Cirrhosis |
---|---|---|---|---|---|---|
1 | 65 | M | 1b | mixed | moderate | − |
2 | 71 | M | 1a | trabecular | well | − |
3 | 75 | F | 1b | pseudoglandular | moderate | + |
4 | 68 | F | 1b | mixed | poor | − |
5 | 73 | M | 1b | trabecular | well | − |
6 | 69 | F | 1b | trabecular | moderate | + |
7 | 56 | M | 1a | trabecular | moderate | − |
8 | 79 | M | 1b | mixed | moderate | + |
9 | 61 | M | 2 | trabecular | poor | − |
10 | 74 | M | 1a | solid | moderate | + |
11 | 79 | M | 2 | mixed | moderate | − |
12 | 55 | M | 1a | trabecular | well | + |
13 | 82 | F | 2 | trabecular | moderate | − |
14 | 52 | M | 1a | trabecular | moderate | + |
15 | 71 | M | 1b | mixed | moderate | − |
16 | 66 | M | 2 | mixed | well | + |
17 | 62 | M | 1a | trabecular | moderate | + |
18 | 62 | F | 2 | trabecular | moderate | − |
19 | 64 | F | 2 | trabecular | well | + |
20 | 68 | M | 2 | mixed | moderate | − |
21 | 59 | M | 1a | pseudoglandular | moderate | − |
22 | 73 | M | 2 | trabecular | moderate | − |
23 | 61 | F | 1a | mixed | well | + |
24 | 63 | M | 1a | pseudoglandular | well | − |
25 | 73 | F | 1b | mixed | moderate | − |
26 | 70 | M | 1b | mixed | moderate | − |
27 | 70 | M | 1a | trabecular | moderate | − |
28 | 69 | M | 1a | trabecular | moderate | + |
29 | 60 | F | 1a | trabecular | well | + |
30 | 62 | M | 1b | trabecular | moderate | − |
31 | 57 | M | 1b | mixed | moderate | − |
32 | 74 | F | 1a | trabecular | well | − |
33 | 61 | M | 1b | mixed | moderate | − |
34 | 64 | F | 1a | trabecular | well | + |
35 | 57 | F | 1b | solid | poor | − |
36 | 55 | M | 1b | trabecular | poor | + |
37 | 69 | M | 1b | mixed | moderate | − |
38 | 50 | M | 2 | trabecular | moderate | + |
39 | 77 | F | 2 | mixed | moderate | − |
40 | 69 | F | 1a | trabecular | moderate | + |
Tumour stage, tumour grade and growth pattern are classified according to the WHO (2019) classification. Stage1a: Solitary tumor 2 cm or less in greatest dimension with or without vascular invasion. Stage1b: Solitary tumor more than 2 cm in greatest dimension without vascular invasion. Stage2: Solitary tumor with vascular invasion more than 2 cm dimension or multiple tumors, none more than 5 cm in greatest dimension.